TTOO Ev To Operating Cash Flow vs Inventory Turnover Analysis

TTOO Stock  USD 0.45  0.03  6.25%   
T2 Biosystms financial indicator trend analysis is much more than just breaking down T2 Biosystms prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether T2 Biosystms is a good investment. Please check the relationship between T2 Biosystms Ev To Operating Cash Flow and its Inventory Turnover accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

Ev To Operating Cash Flow vs Inventory Turnover

Ev To Operating Cash Flow vs Inventory Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of T2 Biosystms Ev To Operating Cash Flow account and Inventory Turnover. At this time, the significance of the direction appears to have pay attention.
The correlation between T2 Biosystms' Ev To Operating Cash Flow and Inventory Turnover is -0.75. Overlapping area represents the amount of variation of Ev To Operating Cash Flow that can explain the historical movement of Inventory Turnover in the same time period over historical financial statements of T2 Biosystms, assuming nothing else is changed. The correlation between historical values of T2 Biosystms' Ev To Operating Cash Flow and Inventory Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Operating Cash Flow of T2 Biosystms are associated (or correlated) with its Inventory Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory Turnover has no effect on the direction of Ev To Operating Cash Flow i.e., T2 Biosystms' Ev To Operating Cash Flow and Inventory Turnover go up and down completely randomly.

Correlation Coefficient

-0.75
Relationship DirectionNegative 
Relationship StrengthWeak

Ev To Operating Cash Flow

A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.
Most indicators from T2 Biosystms' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.As of the 12th of December 2024, Enterprise Value is likely to grow to about 75.5 M, while Selling General Administrative is likely to drop about 26 M.
 2021 2022 2023 2024 (projected)
Interest Expense6.6M6.1M5.3M4.9M
Depreciation And Amortization2.5M2.3M859K1.1M

T2 Biosystms fundamental ratios Correlations

0.490.240.00.920.060.6-0.33-0.130.080.810.590.450.260.380.920.15-0.090.34-0.350.280.33-0.560.310.97-0.07
0.490.780.490.440.610.930.61-0.870.580.040.87-0.080.380.840.160.790.230.4-0.50.850.96-0.30.780.310.39
0.240.780.830.290.270.620.52-0.730.71-0.030.510.03-0.010.690.010.530.310.1-0.740.620.79-0.310.610.130.75
0.00.490.830.10.20.290.41-0.60.37-0.040.160.08-0.430.37-0.090.40.61-0.2-0.810.320.54-0.290.58-0.030.99
0.920.440.290.1-0.060.5-0.37-0.090.020.820.450.460.210.350.880.07-0.040.17-0.580.220.29-0.830.270.920.04
0.060.610.270.2-0.060.560.71-0.830.32-0.330.6-0.190.180.57-0.210.950.610.42-0.030.810.70.090.81-0.090.16
0.60.930.620.290.50.560.48-0.730.540.150.940.060.40.740.290.690.120.47-0.350.720.84-0.270.740.430.18
-0.330.610.520.41-0.370.710.48-0.810.59-0.750.52-0.390.140.53-0.650.790.340.38-0.090.690.70.260.58-0.510.36
-0.13-0.87-0.73-0.6-0.09-0.83-0.73-0.81-0.570.27-0.680.24-0.17-0.80.18-0.95-0.57-0.280.43-0.89-0.940.1-0.880.03-0.53
0.080.580.710.370.020.320.540.59-0.57-0.280.51-0.140.210.61-0.180.50.030.37-0.220.580.570.040.42-0.050.26
0.810.04-0.03-0.040.82-0.330.15-0.750.27-0.280.040.420.040.00.96-0.29-0.09-0.2-0.34-0.19-0.11-0.61-0.010.92-0.06
0.590.870.510.160.450.60.940.52-0.680.510.040.160.360.680.250.70.060.72-0.210.720.78-0.180.670.390.06
0.45-0.080.030.080.46-0.190.06-0.390.24-0.140.420.16-0.54-0.10.5-0.20.10.24-0.27-0.17-0.1-0.330.080.470.09
0.260.38-0.01-0.430.210.180.40.14-0.170.210.040.36-0.540.280.110.21-0.520.260.250.390.28-0.01-0.060.19-0.51
0.380.840.690.370.350.570.740.53-0.80.610.00.68-0.10.280.090.730.270.32-0.390.860.88-0.230.690.240.28
0.920.160.01-0.090.88-0.210.29-0.650.18-0.180.960.250.50.110.09-0.16-0.130.07-0.3-0.05-0.01-0.590.070.98-0.12
0.150.790.530.40.070.950.690.79-0.950.5-0.290.7-0.20.210.73-0.160.590.43-0.270.910.86-0.060.88-0.010.34
-0.090.230.310.61-0.040.610.120.34-0.570.03-0.090.060.1-0.520.27-0.130.59-0.19-0.460.370.37-0.20.75-0.10.64
0.340.40.1-0.20.170.420.470.38-0.280.37-0.20.720.240.260.320.070.43-0.190.20.480.350.130.220.18-0.26
-0.35-0.5-0.74-0.81-0.58-0.03-0.35-0.090.43-0.22-0.34-0.21-0.270.25-0.39-0.3-0.27-0.460.2-0.28-0.470.78-0.5-0.35-0.79
0.280.850.620.320.220.810.720.69-0.890.58-0.190.72-0.170.390.86-0.050.910.370.48-0.280.92-0.120.760.120.24
0.330.960.790.540.290.70.840.7-0.940.57-0.110.78-0.10.280.88-0.010.860.370.35-0.470.92-0.190.820.160.45
-0.56-0.3-0.31-0.29-0.830.09-0.270.260.10.04-0.61-0.18-0.33-0.01-0.23-0.59-0.06-0.20.130.78-0.12-0.19-0.27-0.6-0.26
0.310.780.610.580.270.810.740.58-0.880.42-0.010.670.08-0.060.690.070.880.750.22-0.50.760.82-0.270.180.52
0.970.310.13-0.030.92-0.090.43-0.510.03-0.050.920.390.470.190.240.98-0.01-0.10.18-0.350.120.16-0.60.18-0.08
-0.070.390.750.990.040.160.180.36-0.530.26-0.060.060.09-0.510.28-0.120.340.64-0.26-0.790.240.45-0.260.52-0.08
Click cells to compare fundamentals

T2 Biosystms Account Relationship Matchups

T2 Biosystms fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets28.5M79.1M60.5M34.4M34.8M43.7M
Short Long Term Debt Total44.8M55.8M57.1M59.2M49.5M42.0M
Other Current Liab13.6M6.4M7.2M6.0M9.9M6.8M
Total Current Liabilities60.6M9.8M11.7M10.5M56.2M59.0M
Total Stockholder Equity(34.0M)8.7M(12.9M)(40.0M)(28.0M)(26.6M)
Other Liab46K4.8M4.6M4.9M5.6M5.9M
Property Plant And Equipment Net9.2M14.8M14.4M13.3M9.1M9.8M
Net Debt33.7M39.0M34.9M48.9M33.8M35.5M
Retained Earnings(376.2M)(423.0M)(472.2M)(534.5M)(584.3M)(555.1M)
Accounts Payable3.8M2.1M2.8M1.3M1.5M1.6M
Cash11.0M16.8M22.2M10.3M15.7M28.6M
Non Current Assets Total9.6M25.5M16.1M15.0M9.6M11.6M
Cash And Short Term Investments11.0M42.2M32.2M10.3M15.7M31.0M
Common Stock Total Equity36K44K51K147K169.1K177.5K
Common Stock Shares Outstanding9.1K24.3K31.8K51.0K2.6M2.7M
Liabilities And Stockholders Equity28.5M79.1M60.5M34.4M34.8M43.7M
Non Current Liabilities Total1.9M60.6M61.8M63.9M6.7M6.3M
Other Current Assets1.4M2.7M3.1M2.6M3.3M1.7M
Other Stockholder Equity342.1M431.5M459.2M494.6M556.3M315.0M
Total Liab62.5M70.4M73.4M74.4M62.8M50.8M
Property Plant And Equipment Gross9.2M14.8M14.4M13.3M23.9M25.1M
Total Current Assets18.9M53.6M44.4M19.4M25.2M35.3M
Short Term Debt42.9M1.2M1.2M2.7M44.5M46.7M
Common Stock49K147K166K8K4K3.8K
Property Plant Equipment5.8M14.8M14.4M13.3M15.3M9.5M
Net Tangible Assets(32.1M)8.7M(12.9M)(40.0M)(36.0M)(34.2M)
Current Deferred Revenue285K230K518K172K224K212.8K
Net Receivables2.8M5.1M5.1M2.2M1.4M2.2M
Retained Earnings Total Equity(266.1M)(317.2M)(376.2M)(423.0M)(380.7M)(399.7M)
Capital Surpluse267.4M328.5M342.1M431.5M496.3M308.8M
Inventory3.6M3.6M3.9M4.3M4.8M2.9M
Short Long Term Debt40.7M42.4M42.9M41.3M47.5M27.2M
Capital Lease Obligations3.9M10.5M9.4M9.6M8.2M6.1M

Pair Trading with T2 Biosystms

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if T2 Biosystms position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in T2 Biosystms will appreciate offsetting losses from the drop in the long position's value.

Moving together with TTOO Stock

  0.83VALN Valneva SE ADRPairCorr
  0.77ERNA Eterna TherapeuticsPairCorr

Moving against TTOO Stock

  0.93BMY Bristol Myers SquibbPairCorr
  0.9GILD Gilead SciencesPairCorr
  0.73ESPR Esperion TherapeuticsPairCorr
  0.47DYAI Dyadic InternationalPairCorr
  0.42DNA Ginkgo Bioworks HoldingsPairCorr
The ability to find closely correlated positions to T2 Biosystms could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace T2 Biosystms when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back T2 Biosystms - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling T2 Biosystms to buy it.
The correlation of T2 Biosystms is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as T2 Biosystms moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if T2 Biosystms moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for T2 Biosystms can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.03)
Revenue Per Share
0.999
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.90)
Return On Equity
(6.22)
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.